Author:
Moradi Ghobad,Soheili Marzieh,Rashti Roya,Dehghanbanadaki Hojat,Nouri Elham,Zakaryaei Farima,Amini Elnaz Ezzati,Baiezeedi Sheno,Ahmadi Sanaz,Moradi Yousef
Abstract
Abstract
Objectives
This study aimed to systematically review the literature on the prevalence of hepatitis C virus (HCV) and hepatitis B virus (HBV) infections in transgender and LGBT people and determine their pooled estimates worldwide.
Methods
Databases (PubMed, Scopus, Web of Science, Embase, Ovid, Cochrane, PsycInfo) were searched from April 2000 to July 2021. The analyses were executed using the random-effects model in Stata 16.
Results
Ten studies, including eight studies on four transgender people and two studies on 2150 LGBTs, were included. The pooled prevalence of HCV and HBV in all transgender populations globally were 9% (95% CI 3–15%) and 11% (95% CI 2–20%), respectively. The corresponding prevalence in male-to-female transgender people were estimated as 5% (95% CI 1–9%) and 6% (95% CI 3–10%), respectively. These estimates in American transgenders were 10% (95% CI 5–25%) and 16% (95% CI 8–23%), respectively.
Conclusion
This study was identified the overall prevalence of HBV and HCV infections in transgender people, which were higher than those in the general population.
Funder
Kurdistan university of medical sciences
Publisher
Springer Science and Business Media LLC
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献